New drug`s approval: shot in arm for Biogen
The U.S. Food and Drug Administration has approved Amevive, the first drug from the biotechnology industry to treat psoriasis, a sometimes debilitating skin ailment.Doctors say it will open a new era
The U.S. Food and Drug Administration has approved Amevive, the first drug from the biotechnology industry to treat psoriasis, a sometimes debilitating skin ailment.Doctors say it will open a new era